ALB and cancer: Several systemic inflammatory response (SIR) markers, such as platelet-to-lymphocyte ratio (PLR), neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), and albumin-to-globulin ratio (AGR), have been studied and recognized as prognostic factors in various cancers.